Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma
- DOI
- 10.1158/1535-7163.mct-16-0602-t
- Published
- 2017-10-01
- Container
- Molecular Cancer Therapeutics
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-16-0602-t,
title = {Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma},
author = {Gaël S. Roth and Zuzana Macek Jilkova and Ayca Zeybek Kuyucu and Keerthi Kurma and Séyédéh Tayébéh Ahmad Pour and Giovanni Abbadessa and Yi Yu and Benoit Busser and Patrice N. Marche and Vincent Leroy and Thomas Decaens},
year = {2017},
journal = {Molecular Cancer Therapeutics},
doi = {10.1158/1535-7163.mct-16-0602-t},
url = {https://doi.org/10.1158/1535-7163.mct-16-0602-t}
}RIS
TY - JOUR TI - Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma AU - Gaël S. Roth AU - Zuzana Macek Jilkova AU - Ayca Zeybek Kuyucu AU - Keerthi Kurma AU - Séyédéh Tayébéh Ahmad Pour AU - Giovanni Abbadessa AU - Yi Yu AU - Benoit Busser AU - Patrice N. Marche AU - Vincent Leroy AU - Thomas Decaens PY - 2017 JO - Molecular Cancer Therapeutics DO - 10.1158/1535-7163.mct-16-0602-t UR - https://doi.org/10.1158/1535-7163.mct-16-0602-t ER -
APA
Roth, G. S., Jilkova, Z. M., Kuyucu, A. Z., Kurma, K., Pour, S. T. A., Abbadessa, G., Yu, Y., Busser, B., Marche, P. N., Leroy, V., & Decaens, T. (2017). Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-16-0602-t
Source records
- crossref · retrieved 2026-11-10T19:09:09.083Z